Report Detail

Pharma & Healthcare Global Therapeutic Fc Fusion Protein Market Growth (Status and Outlook) 2022-2028

  • RnM4495589
  • |
  • 24 November, 2022
  • |
  • Global
  • |
  • 100 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
The global market for Therapeutic Fc Fusion Protein is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Therapeutic Fc Fusion Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Therapeutic Fc Fusion Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Therapeutic Fc Fusion Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Therapeutic Fc Fusion Protein market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Therapeutic Fc Fusion Protein players cover Sanofi, Bristol-Myers Squibb, Regeneron, Bayer and Amgen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Therapeutic Fc Fusion Protein market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Therapeutic Fc Fusion Protein market, with both quantitative and qualitative data, to help readers understand how the Therapeutic Fc Fusion Protein market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Therapeutic Fc Fusion Protein market and forecasts the market size by Type (Brands Drugs and Biosimilar Drugs,), by Application (Autoimmune Disease, Eye Diseases, Diabetes and Hemophilia), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Brands Drugs
Biosimilar Drugs

Segmentation by application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma

Chapter Introduction
Chapter 1: Scope of Therapeutic Fc Fusion Protein, Research Methodology, etc.
Chapter 2: Executive Summary, global Therapeutic Fc Fusion Protein market size and CAGR, Therapeutic Fc Fusion Protein market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Therapeutic Fc Fusion Protein revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Therapeutic Fc Fusion Protein revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Therapeutic Fc Fusion Protein market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi, Bristol-Myers Squibb, Regeneron, Bayer, Amgen, Pfizer, Eli Lilly and Company, Sobi and Kanghong Pharma, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Therapeutic Fc Fusion Protein Market Size 2017-2028
    • 2.1.2 Therapeutic Fc Fusion Protein Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Therapeutic Fc Fusion Protein Segment by Type
    • 2.2.1 Brands Drugs
    • 2.2.2 Biosimilar Drugs
  • 2.3 Therapeutic Fc Fusion Protein Market Size by Type
    • 2.3.1 Therapeutic Fc Fusion Protein Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Therapeutic Fc Fusion Protein Market Size Market Share by Type (2017-2022)
  • 2.4 Therapeutic Fc Fusion Protein Segment by Application
    • 2.4.1 Autoimmune Disease
    • 2.4.2 Eye Diseases
    • 2.4.3 Diabetes
    • 2.4.4 Hemophilia
    • 2.4.5 Other
  • 2.5 Therapeutic Fc Fusion Protein Market Size by Application
    • 2.5.1 Therapeutic Fc Fusion Protein Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Therapeutic Fc Fusion Protein Market Size Market Share by Application (2017-2022)

3 Therapeutic Fc Fusion Protein Market Size by Player

  • 3.1 Therapeutic Fc Fusion Protein Market Size Market Share by Players
    • 3.1.1 Global Therapeutic Fc Fusion Protein Revenue by Players (2020-2022)
    • 3.1.2 Global Therapeutic Fc Fusion Protein Revenue Market Share by Players (2020-2022)
  • 3.2 Global Therapeutic Fc Fusion Protein Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Therapeutic Fc Fusion Protein by Regions

  • 4.1 Therapeutic Fc Fusion Protein Market Size by Regions (2017-2022)
  • 4.2 Americas Therapeutic Fc Fusion Protein Market Size Growth (2017-2022)
  • 4.3 APAC Therapeutic Fc Fusion Protein Market Size Growth (2017-2022)
  • 4.4 Europe Therapeutic Fc Fusion Protein Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Therapeutic Fc Fusion Protein Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Therapeutic Fc Fusion Protein Market Size by Country (2017-2022)
  • 5.2 Americas Therapeutic Fc Fusion Protein Market Size by Type (2017-2022)
  • 5.3 Americas Therapeutic Fc Fusion Protein Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Therapeutic Fc Fusion Protein Market Size by Region (2017-2022)
  • 6.2 APAC Therapeutic Fc Fusion Protein Market Size by Type (2017-2022)
  • 6.3 APAC Therapeutic Fc Fusion Protein Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Therapeutic Fc Fusion Protein by Country (2017-2022)
  • 7.2 Europe Therapeutic Fc Fusion Protein Market Size by Type (2017-2022)
  • 7.3 Europe Therapeutic Fc Fusion Protein Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Therapeutic Fc Fusion Protein by Region (2017-2022)
  • 8.2 Middle East & Africa Therapeutic Fc Fusion Protein Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Therapeutic Fc Fusion Protein Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Therapeutic Fc Fusion Protein Market Forecast

  • 10.1 Global Therapeutic Fc Fusion Protein Forecast by Regions (2023-2028)
    • 10.1.1 Global Therapeutic Fc Fusion Protein Forecast by Regions (2023-2028)
    • 10.1.2 Americas Therapeutic Fc Fusion Protein Forecast
    • 10.1.3 APAC Therapeutic Fc Fusion Protein Forecast
    • 10.1.4 Europe Therapeutic Fc Fusion Protein Forecast
    • 10.1.5 Middle East & Africa Therapeutic Fc Fusion Protein Forecast
  • 10.2 Americas Therapeutic Fc Fusion Protein Forecast by Country (2023-2028)
    • 10.2.1 United States Therapeutic Fc Fusion Protein Market Forecast
    • 10.2.2 Canada Therapeutic Fc Fusion Protein Market Forecast
    • 10.2.3 Mexico Therapeutic Fc Fusion Protein Market Forecast
    • 10.2.4 Brazil Therapeutic Fc Fusion Protein Market Forecast
  • 10.3 APAC Therapeutic Fc Fusion Protein Forecast by Region (2023-2028)
    • 10.3.1 China Therapeutic Fc Fusion Protein Market Forecast
    • 10.3.2 Japan Therapeutic Fc Fusion Protein Market Forecast
    • 10.3.3 Korea Therapeutic Fc Fusion Protein Market Forecast
    • 10.3.4 Southeast Asia Therapeutic Fc Fusion Protein Market Forecast
    • 10.3.5 India Therapeutic Fc Fusion Protein Market Forecast
    • 10.3.6 Australia Therapeutic Fc Fusion Protein Market Forecast
  • 10.4 Europe Therapeutic Fc Fusion Protein Forecast by Country (2023-2028)
    • 10.4.1 Germany Therapeutic Fc Fusion Protein Market Forecast
    • 10.4.2 France Therapeutic Fc Fusion Protein Market Forecast
    • 10.4.3 UK Therapeutic Fc Fusion Protein Market Forecast
    • 10.4.4 Italy Therapeutic Fc Fusion Protein Market Forecast
    • 10.4.5 Russia Therapeutic Fc Fusion Protein Market Forecast
  • 10.5 Middle East & Africa Therapeutic Fc Fusion Protein Forecast by Region (2023-2028)
    • 10.5.1 Egypt Therapeutic Fc Fusion Protein Market Forecast
    • 10.5.2 South Africa Therapeutic Fc Fusion Protein Market Forecast
    • 10.5.3 Israel Therapeutic Fc Fusion Protein Market Forecast
    • 10.5.4 Turkey Therapeutic Fc Fusion Protein Market Forecast
    • 10.5.5 GCC Countries Therapeutic Fc Fusion Protein Market Forecast
  • 10.6 Global Therapeutic Fc Fusion Protein Forecast by Type (2023-2028)
  • 10.7 Global Therapeutic Fc Fusion Protein Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Information
    • 11.1.2 Sanofi Therapeutic Fc Fusion Protein Product Offered
    • 11.1.3 Sanofi Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Sanofi Main Business Overview
    • 11.1.5 Sanofi Latest Developments
  • 11.2 Bristol-Myers Squibb
    • 11.2.1 Bristol-Myers Squibb Company Information
    • 11.2.2 Bristol-Myers Squibb Therapeutic Fc Fusion Protein Product Offered
    • 11.2.3 Bristol-Myers Squibb Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Bristol-Myers Squibb Main Business Overview
    • 11.2.5 Bristol-Myers Squibb Latest Developments
  • 11.3 Regeneron
    • 11.3.1 Regeneron Company Information
    • 11.3.2 Regeneron Therapeutic Fc Fusion Protein Product Offered
    • 11.3.3 Regeneron Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Regeneron Main Business Overview
    • 11.3.5 Regeneron Latest Developments
  • 11.4 Bayer
    • 11.4.1 Bayer Company Information
    • 11.4.2 Bayer Therapeutic Fc Fusion Protein Product Offered
    • 11.4.3 Bayer Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Bayer Main Business Overview
    • 11.4.5 Bayer Latest Developments
  • 11.5 Amgen
    • 11.5.1 Amgen Company Information
    • 11.5.2 Amgen Therapeutic Fc Fusion Protein Product Offered
    • 11.5.3 Amgen Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Amgen Main Business Overview
    • 11.5.5 Amgen Latest Developments
  • 11.6 Pfizer
    • 11.6.1 Pfizer Company Information
    • 11.6.2 Pfizer Therapeutic Fc Fusion Protein Product Offered
    • 11.6.3 Pfizer Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Pfizer Main Business Overview
    • 11.6.5 Pfizer Latest Developments
  • 11.7 Eli Lilly and Company
    • 11.7.1 Eli Lilly and Company Company Information
    • 11.7.2 Eli Lilly and Company Therapeutic Fc Fusion Protein Product Offered
    • 11.7.3 Eli Lilly and Company Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Eli Lilly and Company Main Business Overview
    • 11.7.5 Eli Lilly and Company Latest Developments
  • 11.8 Sobi
    • 11.8.1 Sobi Company Information
    • 11.8.2 Sobi Therapeutic Fc Fusion Protein Product Offered
    • 11.8.3 Sobi Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Sobi Main Business Overview
    • 11.8.5 Sobi Latest Developments
  • 11.9 Kanghong Pharma
    • 11.9.1 Kanghong Pharma Company Information
    • 11.9.2 Kanghong Pharma Therapeutic Fc Fusion Protein Product Offered
    • 11.9.3 Kanghong Pharma Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Kanghong Pharma Main Business Overview
    • 11.9.5 Kanghong Pharma Latest Developments
  • 11.10 3SBIO
    • 11.10.1 3SBIO Company Information
    • 11.10.2 3SBIO Therapeutic Fc Fusion Protein Product Offered
    • 11.10.3 3SBIO Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 3SBIO Main Business Overview
    • 11.10.5 3SBIO Latest Developments
  • 11.11 Celgen Biopharma
    • 11.11.1 Celgen Biopharma Company Information
    • 11.11.2 Celgen Biopharma Therapeutic Fc Fusion Protein Product Offered
    • 11.11.3 Celgen Biopharma Therapeutic Fc Fusion Protein Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Celgen Biopharma Main Business Overview
    • 11.11.5 Celgen Biopharma Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Therapeutic Fc Fusion Protein. Industry analysis & Market Report on Therapeutic Fc Fusion Protein is a syndicated market report, published as Global Therapeutic Fc Fusion Protein Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Therapeutic Fc Fusion Protein market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,056.10
6,112.20
3,539.22
7,078.44
506,836.80
1,013,673.60
298,473.00
596,946.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report